Citigroup’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46K | Sell |
13,648
-9,231
| -40% | -$31.1K | ﹤0.01% | 4074 |
|
|
2025
Q1 | $88.3K | Sell |
22,879
-1,597
| -7% | -$6.16K | ﹤0.01% | 3902 |
|
|
2024
Q4 | $151K | Buy |
24,476
+1,331
| +6% | +$8.21K | ﹤0.01% | 3775 |
|
|
2024
Q3 | $125K | Buy |
23,145
+15,911
| +220% | +$85.6K | ﹤0.01% | 3890 |
|
|
2024
Q2 | $24.2K | Buy |
7,234
+905
| +14% | +$3.03K | ﹤0.01% | 4206 |
|
|
2024
Q1 | $25.5K | Buy |
6,329
+1,514
| +31% | +$6.1K | ﹤0.01% | 4206 |
|
|
2023
Q4 | $12.8K | Buy |
4,815
+4,041
| +522% | +$10.7K | ﹤0.01% | 4373 |
|
|
2023
Q3 | $1.83K | Sell |
774
-9,942
| -93% | -$23.5K | ﹤0.01% | 4229 |
|
|
2023
Q2 | $67.5K | Buy |
10,716
+7,309
| +215% | +$46K | ﹤0.01% | 3791 |
|
|
2023
Q1 | $19.7K | Sell |
3,407
-106,253
| -97% | -$613K | ﹤0.01% | 3875 |
|
|
2022
Q4 | $1.13M | Buy |
109,660
+75,393
| +220% | +$774K | ﹤0.01% | 1931 |
|
|
2022
Q3 | $573K | Buy |
34,267
+25,753
| +302% | +$431K | ﹤0.01% | 2499 |
|
|
2022
Q2 | $119K | Sell |
8,514
-10,208
| -55% | -$143K | ﹤0.01% | 3465 |
|
|
2022
Q1 | $302K | Sell |
18,722
-9,477
| -34% | -$153K | ﹤0.01% | 3168 |
|
|
2021
Q4 | $604K | Buy |
28,199
+3,391
| +14% | +$72.6K | ﹤0.01% | 2927 |
|
|
2021
Q3 | $364K | Buy |
24,808
+1,118
| +5% | +$16.4K | ﹤0.01% | 3101 |
|
|
2021
Q2 | $471K | Buy |
+23,690
| New | +$471K | ﹤0.01% | 3113 |
|